Boeing Co (NYSE:BA) won a $241.3 million sole-source contract from the U.S. Navy on September 4. The award covers repairs to flight-control surfaces for F/A-18E/F Super Hornets and EA-18G Growlers. The work extends through September 2032.
The latest Navy contract highlights a key advantage as Boeing works through its commercial aircraft recovery. It's the company's well-established defense installed base that can generate recurring demand.
The investment case, however, is not simply that Boeing can keep winning defense contracts. Instead, the thesis holds only if growing defense demand translates into sustainable operating profit and free cash flow while the commercial aircraft segment continues to improve.
Jirat Teparaksa/Shutterstock.com
The latest Navy award adds to Boeing's growing list of Pentagon contracts. Boeing also received a $109 million sole-source Navy order for 76 F/A-18 outer-wing panels on August 10. Work on that contract is scheduled through October 2031. The two multi-year Navy awards demonstrate Boeing's established position in the F/A-18 sustainment.
The opportunity also extends beyond sustainment. The U.S. recently approved a potential $5 billion Saudi Arabian purchase of JDAM-ER weapons, with Boeing designated as the principal contractor. Although the proposed sale is not booked revenue, it illustrates the broader defense opportunities available to the company.
Boeing's Defense, Space & Security segment revenue increased 13% YoY to about $7.5 billion in Q2. But the segment also posted a $15 million operating loss, contrasting sharply with a $110 million profit a year ago. Results included $280 million in losses on the VC-25B program, primarily driven by investments in additional production and certification resources.
Boeing Co (NYSE:BA)'s total revenue increased 8% to around $24.6 billion in Q2, supported by 171 commercial aircraft deliveries. Commercial Airplanes segment revenue jumped 8% to $11.8 billion, and loss from operations narrowed to $322 million from $557 million. The commercial segment remains the business most capable of determining whether a broader turnaround is sustainable.
The bull case requires two things to happen simultaneously. Defense and services should maintain demand and improve profitability, while higher commercial deliveries should translate into better margins and recurring free cash flow.
The bear case is straightforward. Defense revenue can keep rising without producing meaningful earnings if program charges persist. And a slower commercial recovery could continue consuming capital. In that scenario, Boeing's defense franchise would provide revenue but not the financial buffer investors expect.
Investor positioning in Boeing Co (NYSE:BA) reflects that uncertainty. The number of hedge funds holding Boeing stock declined to 90 in Q2 from 99 in Q1. Pentwater Capital Management reduced its stake by 13% to around 6.2 million shares, although the fund had previously increased the position by 7% in Q1 and 165% in Q4. Fisher Asset Management and Viking Global increased their stakes 4% and 3%, respectively.
Short interest was relatively modest at slightly under 15 million shares, or 1.90% of the public float, as of August 14. That was down 3.06% from the prior report. With 2.9 days to cover, the short interest ratio does not indicate an unusually crowded bearish position.
Boeing's defense franchise therefore offers a credible potential buffer. That said, investors still need proof that it can produce profitable cash flow. Rising defense revenue is valuable only if Boeing can execute programs without allowing cost overruns to consume the economics. If defense revenue keeps growing without restoring profitability, the investment case breaks down.
While we acknowledge the potential of BA as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: Johnson & Johnson (JNJ) Taps Sail Biomedicines in Bid for CAR-T Edge Over Bristol Myers Squibb and Ford Motor Company (F)'s Truck Production Rebounds Sharply. Can Sales Catch Up?
Disclosure: None. Follow Insider Monkey on Google News.